ArticleNature medicine2026

An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up.

Keiko Sugai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.